Omocor-Lovaza launch by Joe Z and Paul Huff in 2005
Based on Actual facts, Small co.are fast on feet with less bosses to review every decision.Large co.have too many bosses to MICROMANAGE.
Vertex beat Merck--even after starting 4 weeks delay in FDA approval-gaining 75% Market share in 5 months.
Same thing happened with Omacor/Lovaza--Sales grew 100% to reach 341 mil.$ in 9months of 2007. GSK Press release says that the growth was 62% over same period of 2006.
By the time GSK took over in 2008(as purchase happened on Nov.21,2007), Lovaza sales were 500 mil.$.
GSK grew it from 500 to 900 mil.$ in 4 years to 900 mil.$.
Pronova--owner of patents was able to grow sales to 500mil.$ in other countries. Total sales in 2011--GSK(Lovaza) + Omacor in Europe =900+500$=1400mil.$